Thomas Systchenko

4PUBLICATIONS
25CO-AUTHORS
Epidemiological methodsHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Sep 18, 2026
Social Inequalities, Geographical Accessibility to Care, and Excess Mortality for Patients With Hematological Malignancies in France: Results From French Cancer Registries.

|Aug 27, 2025
Risk of synchronous and second primary malignancies in transplant-ineligible patients with multiple myeloma treated with lenalidomide.

Thomas Systchenko, Laly Nsiala, Arthur Bobin

|May 15, 2023
Combination of azacitidine, venetoclax and ruxolitinib in blast phase myeloproliferative neoplasms.

Thomas Systchenko, Jean-Claude Chomel, Pilar Gallego-Hernanz

|May 27, 2020
R-CHOP appears to be the best first-line treatment for second primary diffuse large B cell lymphoma: a cancer registry study.

T Systchenko, G Defossez, S Guidez

Pageof 1

Frequent Collaborators

1 joint publications

J Gardy

1 joint publications

X Troussard

1 joint publications

M Maynadié

1 joint publications

A Monnereau